Author:
Kaevitser G. A.,Samokhvalov E. I.,Scheblyakov D. V.,Gintsburg A. L.,Vzorov A. N.
Reference41 articles.
1. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., Cohen F.S. 2000. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol.
151, 413–423.
2. Rutten L., Lai Y.T., Blokland S., Truan D., Bisschop I.J.M., Strokappe N.M., Koornneef A., van Manen D., Chuang G.Y., Farney S.K., Schuitemaker H., Kwong P.D., Langedijk J.P.M. 2018. A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers. Cell Rep.
23, 584‒595.
3. Vzorov A.N., Wang L., Wang B.Z., Compans R.W. 2016. Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines. Vir-ology. 489, 141‒150.
4. Vzorov A.N., Compans R.W. 1996. Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains. Virology.
221, 22‒33.
5. Vzorov A.N., Lea-Fox D., Compans R.W. 1999. Immunogenicity of full length and truncated SIV envelope proteins. Viral Immunol. 12, 205‒215.